94,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
47 °P sammeln
  • Broschiertes Buch

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. An invaluable resource to the rapidly emerging field of pharmacogenomics-complete with case studies, clinical pearls, and treatment recommendations The aim of pharmacogenomics is to improve personalized medicine by taking into account how genes affect an individual's tolerability and response to drugs. Approaching pharmacogenomics from the current clinical, scientific, and implementation perspectives, this…mehr

Produktbeschreibung
Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. An invaluable resource to the rapidly emerging field of pharmacogenomics-complete with case studies, clinical pearls, and treatment recommendations The aim of pharmacogenomics is to improve personalized medicine by taking into account how genes affect an individual's tolerability and response to drugs. Approaching pharmacogenomics from the current clinical, scientific, and implementation perspectives, this guide serves as an invaluable evidence-based resource to the subject. Reflecting the shift from genetics to genomics in the pharmaceutical sphere, the book covers pharmacogenomics fundamentals; genotyping tests and evidence; clinical implementation; ethical, legal, and social issues; and more. You'll also find illuminating case scenarios, clinical pearls, and evidence-based recommendations for treatments and alternatives based on CPIC, PharmGKB, and FDA guidelines.
Autorenporträt
Jerika T. Lam, PharmD, AAHIVP, FCSHP, is an Associate Professor of Pharmacy Practice. She is currently a Director on the Board of the California Society of Health System Pharmacists. The editor has published numerous textbook chapters and articles. She has been invited to speak on the topics of HIV, Hepatitis C, as well as other ambulatory topics by nursing and pharmacy professional associations. She has also received grant funding in the areas of translational antiviral research and creative education programs.